NIH/NATIONAL EYE INSTITUTE IMAGE: A 3D VIEW OF COMPLEMENT-ACTIVATED RPE CELLS (GREEN – CYTOSKELETON, BLUE – NUCLEUS) WITH DRUSEN/APOE (RED) DEPOSITS. CREDIT: RUCHI SHARMA AND DAVIDE ORTOLAN (NEI) Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment...
